Kubo M - Search Results

1

Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.

Ihn H, Yazawa N, Kubo M, Yamane K, Sato S, Fujimoto M, Kikuchi K, Soma Y, Tamaki K. Ihn H, et al. Among authors: kubo m. J Rheumatol. 2000 Mar;27(3):698-702. J Rheumatol. 2000. PMID: 10743811

2

Clinical and laboratory features of scleroderma patients with pulmonary hypertension.

Yamane K, Ihn H, Asano Y, Yazawa N, Kubo M, Kikuchi K, Soma Y, Tamaki K. Yamane K, et al. Among authors: kubo m. Rheumatology (Oxford). 2000 Nov;39(11):1269-71. doi: 10.1093/rheumatology/39.11.1269. Rheumatology (Oxford). 2000. PMID: 11085808

3

Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.

Ihn H, Yamane K, Kubo M, Tamaki K. Ihn H, et al. Among authors: kubo m. Arthritis Rheum. 2001 Feb;44(2):474-80. doi: 10.1002/1529-0131(200102)44:2<474::AID-ANR67>3.0.CO;2-#. Arthritis Rheum. 2001. PMID: 11229480 Free article.

4

Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.

Asano Y, Ihn H, Yamane K, Yazawa N, Kubo M, Fujimoto M, Tamaki K. Asano Y, et al. Among authors: kubo m. Arthritis Rheum. 2001 Jun;44(6):1363-9. doi: 10.1002/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5. Arthritis Rheum. 2001. PMID: 11407696 Free article.

5

Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma.

Yamane K, Ihn H, Kubo M, Kuwana M, Asano Y, Yazawa N, Tamaki K. Yamane K, et al. Among authors: kubo m. Rheumatology (Oxford). 2001 Jun;40(6):683-6. doi: 10.1093/rheumatology/40.6.683. Rheumatology (Oxford). 2001. PMID: 11426027

6

Anti-U1RNP antibodies in patients with localized scieroderma.

Yamane K, Ihn H, Kubo M, Kuwana M, Asano Y, Yazawa N, Tamaki K. Yamane K, et al. Among authors: kubo m. Arch Dermatol Res. 2001 Sep;293(9):455-9. doi: 10.1007/s004030100254. Arch Dermatol Res. 2001. PMID: 11758788

7

Anti-U5 snRNP antibody as a possible serological marker for scleroderma-polymyositis overlap.

Kubo M, Ihn H, Kuwana M, Asano Y, Tamaki T, Yamane K, Tamaki K. Kubo M, et al. Rheumatology (Oxford). 2002 May;41(5):531-4. doi: 10.1093/rheumatology/41.5.531. Rheumatology (Oxford). 2002. PMID: 12011376

8

Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease.

Ihn H, Asano Y, Kubo M, Yamane K, Jinnin M, Yazawa N, Fujimoto M, Tamaki K. Ihn H, et al. Among authors: kubo m. Rheumatology (Oxford). 2002 Nov;41(11):1268-72. doi: 10.1093/rheumatology/41.11.1268. Rheumatology (Oxford). 2002. PMID: 12421999

9

Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis.

Asano Y, Ihn H, Kubo M, Jinnin M, Mimura Y, Ashida R, Tamaki K. Asano Y, et al. Among authors: kubo m. Rheumatology (Oxford). 2006 Mar;45(3):303-7. doi: 10.1093/rheumatology/kei143. Epub 2005 Nov 8. Rheumatology (Oxford). 2006. PMID: 16278285

10

Clinical significance of serum matrix metalloproteinase-13 levels in patients with localized scleroderma.

Asano Y, Ihn H, Kubo M, Jinnin M, Mimura Y, Ashida R, Tamaki K. Asano Y, et al. Among authors: kubo m. Clin Exp Rheumatol. 2006 Jul-Aug;24(4):394-9. Clin Exp Rheumatol. 2006. PMID: 16956429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,761 results

Search Page

Filters